Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Oral Contraceptive Market Growth 2022-2028

  • LP 4742841
  • 96 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Oral Contraceptive will have significant change from previous year. According to our (LP Information) latest study, the global Oral Contraceptive market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Oral Contraceptive market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Oral Contraceptive market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oral Contraceptive market, reaching US$ million by the year 2028. As for the Europe Oral Contraceptive landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Oral Contraceptive players cover Pfizer, Inc., Bayer AG, Merck & Co., Inc., and Janssen Global Services, LLC, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Contraceptive market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Combination

Progestin Only

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Male

Female

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Pfizer, Inc.

Bayer AG

Merck & Co., Inc.

Janssen Global Services, LLC

Mankind Pharma Ltd.

Teva Pharmaceutical Industries Ltd

Allergan, plc (Actavis)

Piramal Enterprises Ltd.

Beijing Zizhu Pharm

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Oral Contraceptive Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Oral Contraceptive by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Oral Contraceptive by Country/Region, 2017, 2022 & 2028

2.2 Oral Contraceptive Segment by Type

2.2.1 Combination

2.2.2 Progestin Only

2.2.3 Others

2.3 Oral Contraceptive Sales by Type

2.3.1 Global Oral Contraceptive Sales Market Share by Type (2017-2022)

2.3.2 Global Oral Contraceptive Revenue and Market Share by Type (2017-2022)

2.3.3 Global Oral Contraceptive Sale Price by Type (2017-2022)

2.4 Oral Contraceptive Segment by Application

2.4.1 Male

2.4.2 Female

2.5 Oral Contraceptive Sales by Application

2.5.1 Global Oral Contraceptive Sale Market Share by Application (2017-2022)

2.5.2 Global Oral Contraceptive Revenue and Market Share by Application (2017-2022)

2.5.3 Global Oral Contraceptive Sale Price by Application (2017-2022)

3 Global Oral Contraceptive by Company

3.1 Global Oral Contraceptive Breakdown Data by Company

3.1.1 Global Oral Contraceptive Annual Sales by Company (2020-2022)

3.1.2 Global Oral Contraceptive Sales Market Share by Company (2020-2022)

3.2 Global Oral Contraceptive Annual Revenue by Company (2020-2022)

3.2.1 Global Oral Contraceptive Revenue by Company (2020-2022)

3.2.2 Global Oral Contraceptive Revenue Market Share by Company (2020-2022)

3.3 Global Oral Contraceptive Sale Price by Company

3.4 Key Manufacturers Oral Contraceptive Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Oral Contraceptive Product Location Distribution

3.4.2 Players Oral Contraceptive Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Oral Contraceptive by Geographic Region

4.1 World Historic Oral Contraceptive Market Size by Geographic Region (2017-2022)

4.1.1 Global Oral Contraceptive Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Oral Contraceptive Annual Revenue by Geographic Region

4.2 World Historic Oral Contraceptive Market Size by Country/Region (2017-2022)

4.2.1 Global Oral Contraceptive Annual Sales by Country/Region (2017-2022)

4.2.2 Global Oral Contraceptive Annual Revenue by Country/Region

4.3 Americas Oral Contraceptive Sales Growth

4.4 APAC Oral Contraceptive Sales Growth

4.5 Europe Oral Contraceptive Sales Growth

4.6 Middle East & Africa Oral Contraceptive Sales Growth

5 Americas

5.1 Americas Oral Contraceptive Sales by Country

5.1.1 Americas Oral Contraceptive Sales by Country (2017-2022)

5.1.2 Americas Oral Contraceptive Revenue by Country (2017-2022)

5.2 Americas Oral Contraceptive Sales by Type

5.3 Americas Oral Contraceptive Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Oral Contraceptive Sales by Region

6.1.1 APAC Oral Contraceptive Sales by Region (2017-2022)

6.1.2 APAC Oral Contraceptive Revenue by Region (2017-2022)

6.2 APAC Oral Contraceptive Sales by Type

6.3 APAC Oral Contraceptive Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Oral Contraceptive by Country

7.1.1 Europe Oral Contraceptive Sales by Country (2017-2022)

7.1.2 Europe Oral Contraceptive Revenue by Country (2017-2022)

7.2 Europe Oral Contraceptive Sales by Type

7.3 Europe Oral Contraceptive Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Oral Contraceptive by Country

8.1.1 Middle East & Africa Oral Contraceptive Sales by Country (2017-2022)

8.1.2 Middle East & Africa Oral Contraceptive Revenue by Country (2017-2022)

8.2 Middle East & Africa Oral Contraceptive Sales by Type

8.3 Middle East & Africa Oral Contraceptive Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Oral Contraceptive

10.3 Manufacturing Process Analysis of Oral Contraceptive

10.4 Industry Chain Structure of Oral Contraceptive

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Oral Contraceptive Distributors

11.3 Oral Contraceptive Customer

12 World Forecast Review for Oral Contraceptive by Geographic Region

12.1 Global Oral Contraceptive Market Size Forecast by Region

12.1.1 Global Oral Contraceptive Forecast by Region (2023-2028)

12.1.2 Global Oral Contraceptive Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Oral Contraceptive Forecast by Type

12.7 Global Oral Contraceptive Forecast by Application

13 Key Players Analysis

13.1 Pfizer, Inc.

13.1.1 Pfizer, Inc. Company Information

13.1.2 Pfizer, Inc. Oral Contraceptive Product Offered

13.1.3 Pfizer, Inc. Oral Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer, Inc. Main Business Overview

13.1.5 Pfizer, Inc. Latest Developments

13.2 Bayer AG

13.2.1 Bayer AG Company Information

13.2.2 Bayer AG Oral Contraceptive Product Offered

13.2.3 Bayer AG Oral Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bayer AG Main Business Overview

13.2.5 Bayer AG Latest Developments

13.3 Merck & Co., Inc.

13.3.1 Merck & Co., Inc. Company Information

13.3.2 Merck & Co., Inc. Oral Contraceptive Product Offered

13.3.3 Merck & Co., Inc. Oral Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck & Co., Inc. Main Business Overview

13.3.5 Merck & Co., Inc. Latest Developments

13.4 Janssen Global Services, LLC

13.4.1 Janssen Global Services, LLC Company Information

13.4.2 Janssen Global Services, LLC Oral Contraceptive Product Offered

13.4.3 Janssen Global Services, LLC Oral Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Janssen Global Services, LLC Main Business Overview

13.4.5 Janssen Global Services, LLC Latest Developments

13.5 Mankind Pharma Ltd.

13.5.1 Mankind Pharma Ltd. Company Information

13.5.2 Mankind Pharma Ltd. Oral Contraceptive Product Offered

13.5.3 Mankind Pharma Ltd. Oral Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Mankind Pharma Ltd. Main Business Overview

13.5.5 Mankind Pharma Ltd. Latest Developments

13.6 Teva Pharmaceutical Industries Ltd

13.6.1 Teva Pharmaceutical Industries Ltd Company Information

13.6.2 Teva Pharmaceutical Industries Ltd Oral Contraceptive Product Offered

13.6.3 Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Teva Pharmaceutical Industries Ltd Main Business Overview

13.6.5 Teva Pharmaceutical Industries Ltd Latest Developments

13.7 Allergan, plc (Actavis)

13.7.1 Allergan, plc (Actavis) Company Information

13.7.2 Allergan, plc (Actavis) Oral Contraceptive Product Offered

13.7.3 Allergan, plc (Actavis) Oral Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Allergan, plc (Actavis) Main Business Overview

13.7.5 Allergan, plc (Actavis) Latest Developments

13.8 Piramal Enterprises Ltd.

13.8.1 Piramal Enterprises Ltd. Company Information

13.8.2 Piramal Enterprises Ltd. Oral Contraceptive Product Offered

13.8.3 Piramal Enterprises Ltd. Oral Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Piramal Enterprises Ltd. Main Business Overview

13.8.5 Piramal Enterprises Ltd. Latest Developments

13.9 Beijing Zizhu Pharm

13.9.1 Beijing Zizhu Pharm Company Information

13.9.2 Beijing Zizhu Pharm Oral Contraceptive Product Offered

13.9.3 Beijing Zizhu Pharm Oral Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Beijing Zizhu Pharm Main Business Overview

13.9.5 Beijing Zizhu Pharm Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Oral Contraceptive Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Oral Contraceptive Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Combination

Table 4. Major Players of Progestin Only

Table 5. Major Players of Others

Table 6. Global Oral Contraceptive Sales by Type (2017-2022) & (K Units)

Table 7. Global Oral Contraceptive Sales Market Share by Type (2017-2022)

Table 8. Global Oral Contraceptive Revenue by Type (2017-2022) & ($ million)

Table 9. Global Oral Contraceptive Revenue Market Share by Type (2017-2022)

Table 10. Global Oral Contraceptive Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Oral Contraceptive Sales by Application (2017-2022) & (K Units)

Table 12. Global Oral Contraceptive Sales Market Share by Application (2017-2022)

Table 13. Global Oral Contraceptive Revenue by Application (2017-2022)

Table 14. Global Oral Contraceptive Revenue Market Share by Application (2017-2022)

Table 15. Global Oral Contraceptive Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Oral Contraceptive Sales by Company (2020-2022) & (K Units)

Table 17. Global Oral Contraceptive Sales Market Share by Company (2020-2022)

Table 18. Global Oral Contraceptive Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Oral Contraceptive Revenue Market Share by Company (2020-2022)

Table 20. Global Oral Contraceptive Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Oral Contraceptive Producing Area Distribution and Sales Area

Table 22. Players Oral Contraceptive Products Offered

Table 23. Oral Contraceptive Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Oral Contraceptive Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Oral Contraceptive Sales Market Share Geographic Region (2017-2022)

Table 28. Global Oral Contraceptive Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Oral Contraceptive Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Oral Contraceptive Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Oral Contraceptive Sales Market Share by Country/Region (2017-2022)

Table 32. Global Oral Contraceptive Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Oral Contraceptive Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Oral Contraceptive Sales by Country (2017-2022) & (K Units)

Table 35. Americas Oral Contraceptive Sales Market Share by Country (2017-2022)

Table 36. Americas Oral Contraceptive Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Oral Contraceptive Revenue Market Share by Country (2017-2022)

Table 38. Americas Oral Contraceptive Sales by Type (2017-2022) & (K Units)

Table 39. Americas Oral Contraceptive Sales Market Share by Type (2017-2022)

Table 40. Americas Oral Contraceptive Sales by Application (2017-2022) & (K Units)

Table 41. Americas Oral Contraceptive Sales Market Share by Application (2017-2022)

Table 42. APAC Oral Contraceptive Sales by Region (2017-2022) & (K Units)

Table 43. APAC Oral Contraceptive Sales Market Share by Region (2017-2022)

Table 44. APAC Oral Contraceptive Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Oral Contraceptive Revenue Market Share by Region (2017-2022)

Table 46. APAC Oral Contraceptive Sales by Type (2017-2022) & (K Units)

Table 47. APAC Oral Contraceptive Sales Market Share by Type (2017-2022)

Table 48. APAC Oral Contraceptive Sales by Application (2017-2022) & (K Units)

Table 49. APAC Oral Contraceptive Sales Market Share by Application (2017-2022)

Table 50. Europe Oral Contraceptive Sales by Country (2017-2022) & (K Units)

Table 51. Europe Oral Contraceptive Sales Market Share by Country (2017-2022)

Table 52. Europe Oral Contraceptive Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Oral Contraceptive Revenue Market Share by Country (2017-2022)

Table 54. Europe Oral Contraceptive Sales by Type (2017-2022) & (K Units)

Table 55. Europe Oral Contraceptive Sales Market Share by Type (2017-2022)

Table 56. Europe Oral Contraceptive Sales by Application (2017-2022) & (K Units)

Table 57. Europe Oral Contraceptive Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Oral Contraceptive Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Oral Contraceptive Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Oral Contraceptive Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Oral Contraceptive Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Oral Contraceptive Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Oral Contraceptive Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Oral Contraceptive Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Oral Contraceptive Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Oral Contraceptive

Table 67. Key Market Challenges & Risks of Oral Contraceptive

Table 68. Key Industry Trends of Oral Contraceptive

Table 69. Oral Contraceptive Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Oral Contraceptive Distributors List

Table 72. Oral Contraceptive Customer List

Table 73. Global Oral Contraceptive Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Oral Contraceptive Sales Market Forecast by Region

Table 75. Global Oral Contraceptive Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Oral Contraceptive Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Oral Contraceptive Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Oral Contraceptive Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Oral Contraceptive Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Oral Contraceptive Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Oral Contraceptive Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Oral Contraceptive Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Oral Contraceptive Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Oral Contraceptive Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Oral Contraceptive Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Oral Contraceptive Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Oral Contraceptive Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Oral Contraceptive Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Oral Contraceptive Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Oral Contraceptive Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Oral Contraceptive Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Oral Contraceptive Revenue Market Share Forecast by Application (2023-2028)

Table 93. Pfizer, Inc. Basic Information, Oral Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 94. Pfizer, Inc. Oral Contraceptive Product Offered

Table 95. Pfizer, Inc. Oral Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Pfizer, Inc. Main Business

Table 97. Pfizer, Inc. Latest Developments

Table 98. Bayer AG Basic Information, Oral Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 99. Bayer AG Oral Contraceptive Product Offered

Table 100. Bayer AG Oral Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Bayer AG Main Business

Table 102. Bayer AG Latest Developments

Table 103. Merck & Co., Inc. Basic Information, Oral Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 104. Merck & Co., Inc. Oral Contraceptive Product Offered

Table 105. Merck & Co., Inc. Oral Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Merck & Co., Inc. Main Business

Table 107. Merck & Co., Inc. Latest Developments

Table 108. Janssen Global Services, LLC Basic Information, Oral Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 109. Janssen Global Services, LLC Oral Contraceptive Product Offered

Table 110. Janssen Global Services, LLC Oral Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Janssen Global Services, LLC Main Business

Table 112. Janssen Global Services, LLC Latest Developments

Table 113. Mankind Pharma Ltd. Basic Information, Oral Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 114. Mankind Pharma Ltd. Oral Contraceptive Product Offered

Table 115. Mankind Pharma Ltd. Oral Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Mankind Pharma Ltd. Main Business

Table 117. Mankind Pharma Ltd. Latest Developments

Table 118. Teva Pharmaceutical Industries Ltd Basic Information, Oral Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 119. Teva Pharmaceutical Industries Ltd Oral Contraceptive Product Offered

Table 120. Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Teva Pharmaceutical Industries Ltd Main Business

Table 122. Teva Pharmaceutical Industries Ltd Latest Developments

Table 123. Allergan, plc (Actavis) Basic Information, Oral Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 124. Allergan, plc (Actavis) Oral Contraceptive Product Offered

Table 125. Allergan, plc (Actavis) Oral Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. Allergan, plc (Actavis) Main Business

Table 127. Allergan, plc (Actavis) Latest Developments

Table 128. Piramal Enterprises Ltd. Basic Information, Oral Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 129. Piramal Enterprises Ltd. Oral Contraceptive Product Offered

Table 130. Piramal Enterprises Ltd. Oral Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. Piramal Enterprises Ltd. Main Business

Table 132. Piramal Enterprises Ltd. Latest Developments

Table 133. Beijing Zizhu Pharm Basic Information, Oral Contraceptive Manufacturing Base, Sales Area and Its Competitors

Table 134. Beijing Zizhu Pharm Oral Contraceptive Product Offered

Table 135. Beijing Zizhu Pharm Oral Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. Beijing Zizhu Pharm Main Business

Table 137. Beijing Zizhu Pharm Latest Developments

List of Figures

Figure 1. Picture of Oral Contraceptive

Figure 2. Oral Contraceptive Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Oral Contraceptive Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Oral Contraceptive Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Oral Contraceptive Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Combination

Figure 10. Product Picture of Progestin Only

Figure 11. Product Picture of Others

Figure 12. Global Oral Contraceptive Sales Market Share by Type in 2021

Figure 13. Global Oral Contraceptive Revenue Market Share by Type (2017-2022)

Figure 14. Oral Contraceptive Consumed in Male

Figure 15. Global Oral Contraceptive Market: Male (2017-2022) & (K Units)

Figure 16. Oral Contraceptive Consumed in Female

Figure 17. Global Oral Contraceptive Market: Female (2017-2022) & (K Units)

Figure 18. Global Oral Contraceptive Sales Market Share by Application (2017-2022)

Figure 19. Global Oral Contraceptive Revenue Market Share by Application in 2021

Figure 20. Oral Contraceptive Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Oral Contraceptive Revenue Market Share by Company in 2021

Figure 22. Global Oral Contraceptive Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Oral Contraceptive Revenue Market Share by Geographic Region in 2021

Figure 24. Global Oral Contraceptive Sales Market Share by Region (2017-2022)

Figure 25. Global Oral Contraceptive Revenue Market Share by Country/Region in 2021

Figure 26. Americas Oral Contraceptive Sales 2017-2022 (K Units)

Figure 27. Americas Oral Contraceptive Revenue 2017-2022 ($ Millions)

Figure 28. APAC Oral Contraceptive Sales 2017-2022 (K Units)

Figure 29. APAC Oral Contraceptive Revenue 2017-2022 ($ Millions)

Figure 30. Europe Oral Contraceptive Sales 2017-2022 (K Units)

Figure 31. Europe Oral Contraceptive Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Oral Contraceptive Sales 2017-2022 (K Units)

Figure 33. Middle East & Africa Oral Contraceptive Revenue 2017-2022 ($ Millions)

Figure 34. Americas Oral Contraceptive Sales Market Share by Country in 2021

Figure 35. Americas Oral Contraceptive Revenue Market Share by Country in 2021

Figure 36. United States Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Oral Contraceptive Sales Market Share by Region in 2021

Figure 41. APAC Oral Contraceptive Revenue Market Share by Regions in 2021

Figure 42. China Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Oral Contraceptive Sales Market Share by Country in 2021

Figure 49. Europe Oral Contraceptive Revenue Market Share by Country in 2021

Figure 50. Germany Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Oral Contraceptive Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Oral Contraceptive Revenue Market Share by Country in 2021

Figure 57. Egypt Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Oral Contraceptive in 2021

Figure 63. Manufacturing Process Analysis of Oral Contraceptive

Figure 64. Industry Chain Structure of Oral Contraceptive

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390